LMC Clinical Research Inc. (Thornhill)

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease2 trials
• Obesity2 trials
• Type 2 diabetes2 trials
• Type 1 diabetes1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Completed4 trials

Lead sponsor

• Eli Lilly and Company3 trials
• Boehringer Ingelheim1 trial

Closed trials

• Completed

  A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

  NCT05882045· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

  NCT05536804· Phase 2· Eli Lilly and Company· Source

• Completed

  A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

  NCT04255433· Phase 3· Eli Lilly and Company· Source

• Completed

  EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

  NCT03594110· Phase 3· Boehringer Ingelheim· Source